-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Actuate Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2023 to Q3 2025.
- Actuate Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$5.47M, a 1.47% decline year-over-year.
- Actuate Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$24.4M.
- Actuate Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$25.2M, a 0.75% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)